|
Volumn 340, Issue , 2010, Pages
|
Withdrawal of sibutramine leaves European doctors with just one obesity drug.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANOREXIGENIC AGENT;
CYCLOBUTANE DERIVATIVE;
SIBUTRAMINE;
DRUG RECALL;
EUROPE;
HUMAN;
NOTE;
OBESITY;
APPETITE DEPRESSANTS;
CYCLOBUTANES;
DRUG RECALLS;
EUROPE;
HUMANS;
OBESITY;
|
EID: 77449093032
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.c477 Document Type: Note |
Times cited : (17)
|
References (0)
|